SOTAC — Sotac Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.53bn
- IN₹2.00bn
- IN₹969.87m
- 45
- 28
- 61
- 41
Annual cashflow statement for Sotac Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.6 | 46.9 | 59.6 | 39.6 | 111 |
| Depreciation | |||||
| Non-Cash Items | 11.8 | 23 | 7.57 | -7.88 | 24.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -20.3 | -17.7 | 1.89 | -224 | -217 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.07 | 63.5 | 85.4 | -161 | -43.3 |
| Capital Expenditures | -31.6 | -35 | -70.4 | -178 | -170 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.692 | -0.111 | -38.9 | -18.9 | 34 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -32.3 | -35.2 | -109 | -197 | -136 |
| Financing Cash Flow Items | -8.16 | -35.4 | 47.6 | -81.7 | -27.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 33.8 | -28.3 | 120 | 295 | 161 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.59 | 0.048 | 95.7 | -62.6 | -18.5 |